data_2mau_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mau _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.833 0.349 . . . . 52.55 110.918 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.49 156.62 23.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.41 111.097 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.929 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 177.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.87 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.66 22.73 8.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.674 -0.774 . . . . 54.41 112.462 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -131.91 162.84 29.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 65.35 110.877 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -56.7 148.77 19.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.957 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -148.81 145.05 27.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.878 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 p -164.26 177.57 8.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.788 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 m -49.82 -31.39 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 71.34 111.13 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.02 -36.74 14.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.93 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.44 96.26 10.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 53.21 110.865 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.54 152.46 39.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 72.31 110.918 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.77 147.54 45.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 54.02 110.909 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 114.04 26.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.9 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.12 161.09 0.38 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.539 0.685 . . . . 72.41 110.845 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.78 -10.44 11.55 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.63 -1.821 . . . . 74.1 112.299 -0.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -46.36 104.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 72.11 110.925 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -106.16 137.58 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 74.21 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 22.9 m -73.17 147.08 45.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.911 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -87.27 -50.59 6.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.13 111.134 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -149.36 68.71 9.41 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.567 0.699 . . . . 73.33 110.942 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.27 23.17 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.699 2.266 . . . . 74.44 112.348 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.89 -31.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 73.54 111.093 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 19.2 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.12 111.138 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 92.99 0.81 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.517 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.06 -160.36 8.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 44.11 112.528 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.37 176.07 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 74.22 111.123 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 10.8 m -103.96 156.71 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.887 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 64.14 111.114 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.756 0.312 . . . . 73.13 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.21 156.08 21.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.24 111.055 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.44 149.04 23.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.921 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 177.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 70.35 110.95 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.75 8.73 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.694 -0.765 . . . . 74.04 112.53 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.57 161.37 32.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 73.31 110.893 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.18 147.64 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 65.22 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.51 144.89 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 72.42 110.928 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 p -164.64 177.14 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.51 110.805 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -49.95 -31.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 75.14 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -89.87 -36.64 14.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 74.45 110.932 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 98.25 11.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.86 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 154.29 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.5 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -123.44 148.25 46.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.33 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 114.14 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.816 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.495 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.32 161.15 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 54.32 110.893 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.9 Cg_endo -69.75 -10.68 11.6 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.644 -1.815 . . . . 72.32 112.304 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.48 104.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.25 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -106.18 137.37 44.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.873 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 15.9 m -73.5 147.38 44.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -87.28 -56.45 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 71.02 111.126 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.53 69.45 20.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 75.24 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -8.22 23.05 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 71.01 112.345 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.86 -31.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 70.55 111.147 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.39 19.7 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.34 111.068 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 92.18 0.78 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.799 -0.715 . . . . 64.54 112.498 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.69 -159.73 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 74.13 112.407 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.79 174.82 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 74.23 111.159 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 8.7 m -103.1 156.19 17.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 53.54 110.984 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 74.32 111.054 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.769 0.319 . . . . 65.43 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.94 172.09 9.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 63.22 111.131 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -92.38 157.79 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 75.22 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.429 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -51.74 178.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.45 110.899 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.54 17.22 25.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 65.32 112.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -113.96 153.96 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 75.42 110.899 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -66.6 113.81 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 75.24 110.869 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -106.53 143.82 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 63.25 110.85 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -149.42 -177.92 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.825 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -58.71 -20.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 72.14 111.129 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.94 -50.39 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 74.22 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.82 129.98 36.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.963 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 163.16 31.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.873 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -114.84 177.89 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 63.03 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.02 140.36 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.515 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 3.0 m-20 -50.5 157.67 1.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 74.42 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -10.47 11.63 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.612 -1.828 . . . . 73.24 112.344 0.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -48.67 118.37 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.2 110.957 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -122.42 137.47 54.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.851 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 m -72.28 143.69 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.54 110.962 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -88.1 -60.21 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 71.25 111.126 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -143.3 73.52 17.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.562 0.696 . . . . 73.33 110.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -8.58 23.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.657 2.238 . . . . 64.01 112.356 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 -33.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 70.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.73 21.23 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.22 111.108 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 86.98 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 70.31 112.558 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.93 -158.51 10.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.711 -0.757 . . . . 63.31 112.492 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.42 174.87 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 65.23 111.104 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -101.5 151.12 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 65.41 110.899 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 53.45 111.053 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.851 0.358 . . . . 74.31 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.86 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 72.15 111.09 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -89.55 150.38 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 71.43 110.912 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 175.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.891 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.19 22.83 10.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 71.11 112.478 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -130.79 161.6 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 74.51 110.881 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -54.62 148.72 11.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.927 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.3 t -144.94 142.12 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.42 110.896 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 p -166.54 178.62 5.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 61.24 110.867 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.25 -31.97 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -90.04 -36.96 14.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 74.12 110.86 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.58 91.44 8.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 74.11 110.885 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 153.92 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 74.22 110.867 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -122.97 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.873 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.16 115.39 27.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.858 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.471 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -51.11 162.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 75.02 110.887 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.7 Cg_endo -69.72 -9.72 11.07 Favored 'Cis proline' 0 C--O 1.232 0.2 0 C-N-CA 122.722 -1.782 . . . . 64.5 112.302 -0.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.2 104.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 72.32 110.885 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -104.75 138.73 40.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 72.03 110.763 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 18.5 m -75.95 146.04 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.03 110.845 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -78.53 -53.21 7.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.507 . . . . 64.23 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.06 79.16 14.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 73.21 110.888 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 62.57 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.73 2.287 . . . . 71.23 112.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.3 p -166.91 -35.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 73.11 111.137 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.45 14.67 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.05 111.092 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.17 56.57 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.05 112.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.99 -164.49 37.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.531 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.77 174.57 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 74.12 111.162 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 m -100.68 159.11 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 64.14 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 64.44 111.112 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.886 0.374 . . . . 72.52 110.848 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 166.43 23.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.24 111.132 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.89 153.22 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 71.24 110.944 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 175.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.926 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.22 23.17 7.81 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 65.25 112.506 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -127.13 165.87 18.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 64.23 110.866 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -57.32 142.59 42.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.911 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -150.78 113.15 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.818 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -111.47 171.66 7.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.43 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.0 m -53.82 -25.31 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.14 111.115 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -89.72 -54.63 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.917 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pp -97.98 123.01 41.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 75.51 110.876 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -121.71 -172.3 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -120.62 -175.18 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.926 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.43 132.95 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.897 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.483 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -49.88 160.68 0.61 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 73.01 110.85 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.2 Cg_endo -69.8 -10.27 11.49 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.71 -1.788 . . . . 74.11 112.35 0.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -47.85 121.8 4.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 71.21 110.982 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -123.4 144.25 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.918 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 152.36 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.925 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -104.84 -22.02 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 63.12 111.108 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -179.53 76.37 0.19 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.582 0.706 . . . . 73.13 110.902 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -5.56 16.52 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 75.1 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.4 -31.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.119 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.31 20.49 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 74.01 111.096 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.2 62.38 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.78 -0.724 . . . . 64.54 112.488 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.85 -151.36 24.99 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.503 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 pt -139.71 -178.28 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 75.3 111.155 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.4 m -105.67 148.8 26.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 25.43 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.35 111.111 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.837 0.351 . . . . 72.15 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.13 155.93 24.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.12 111.074 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.57 159.51 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.904 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 167.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 70.53 110.909 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 47.26 31.86 6.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.493 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 159.48 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 62.12 110.898 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -48.84 149.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.934 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.3 t -150.39 141.24 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 64.23 110.916 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.3 p -165.09 174.5 10.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.956 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 m -51.16 -29.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 55.1 111.064 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.14 -38.92 13.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.967 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 106.66 18.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.53 110.912 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -81.01 158.44 25.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.913 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 t -121.17 146.14 47.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 73.41 110.933 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.1 115.36 30.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.21 160.59 0.42 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 72.41 110.819 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.0 Cg_endo -69.66 -11.62 11.75 Favored 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 -1.798 . . . . 71.0 112.369 -0.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -48.05 105.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.863 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -99.81 149.93 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.89 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.4 t -85.18 154.83 21.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -98.21 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 75.2 111.134 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -146.9 78.95 10.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 75.45 110.931 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -8.17 22.92 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.625 2.216 . . . . 71.41 112.33 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.69 -34.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 63.41 111.154 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.8 24.17 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.121 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.96 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.411 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.85 -153.73 11.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 72.11 112.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.46 174.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 75.44 111.148 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.8 m -96.08 144.33 26.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 54.22 110.88 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 65.24 111.173 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.838 0.352 . . . . 74.32 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.31 175.96 6.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 73.42 111.102 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.71 125.98 35.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 73.11 110.901 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -175.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.858 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.95 20.72 6.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.679 -0.772 . . . . 64.44 112.466 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.94 171.54 14.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 73.22 110.907 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.75 146.27 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.96 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.42 142.76 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 52.34 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -149.89 174.79 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 71.54 110.883 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.8 m -51.66 -28.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 70.43 111.132 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.76 -46.64 8.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.926 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.65 113.82 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 73.44 110.92 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -108.86 155.62 20.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 70.41 110.915 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 p -113.77 165.98 12.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 134.26 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.876 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.47 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -63.63 166.55 9.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 61.02 110.905 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.73 -14.51 12.44 Favored 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.723 -1.782 . . . . 71.14 112.332 0.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -48.21 116.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.31 110.954 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -117.88 146.78 43.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.844 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 13.8 m -70.01 147.56 49.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.882 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 p -85.89 -50.88 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.42 111.126 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -150.08 76.09 8.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.634 0.73 . . . . 75.33 110.971 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -7.67 21.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 52.54 112.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 -33.72 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 75.41 111.172 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.73 18.98 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.33 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.16 84.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 72.05 112.488 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.93 -156.08 9.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 75.55 112.448 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -140.29 166.47 19.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 74.12 111.075 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 56.5 m -100.23 155.36 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 54.12 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 64.45 111.08 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.864 0.364 . . . . 71.13 110.869 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.51 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.51 111.127 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -89.47 158.41 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.5 110.985 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 171.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.905 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.37 4.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 75.45 112.474 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 157.93 44.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 72.44 110.884 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -48.46 149.73 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.889 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 t -150.73 140.28 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 53.04 110.937 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -165.12 174.25 10.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 72.41 110.862 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 m -50.63 -29.4 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.152 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -89.05 -38.35 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.933 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 105.57 17.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.12 110.942 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -77.32 158.93 29.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 63.15 110.903 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -126.62 145.03 50.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.884 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 117.07 33.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.962 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -51.0 162.54 0.58 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 74.12 110.886 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -11.03 11.89 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.669 -1.805 . . . . 72.31 112.318 0.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -49.07 104.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.907 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -98.85 151.84 20.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 75.11 110.856 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -78.71 160.99 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 71.14 110.856 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 -27.01 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 75.44 111.056 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -154.41 64.09 4.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 75.32 110.905 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.97 19.88 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.638 2.225 . . . . 73.42 112.354 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 -35.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.52 111.136 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.53 34.67 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 72.34 111.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.63 101.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.765 . . . . 63.01 112.461 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.61 -142.25 5.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.825 -0.702 . . . . 64.51 112.561 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.72 175.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 75.53 111.148 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.7 138.59 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.906 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.31 111.061 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 74.24 110.963 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 159.09 15.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.44 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.14 157.88 18.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 70.33 110.924 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.79 167.0 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.24 110.883 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 45.42 36.64 5.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 70.4 112.539 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.09 160.1 35.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.873 0.368 . . . . 62.01 110.895 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.86 149.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 72.33 110.883 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.3 t -150.38 141.8 23.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 74.4 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 100.0 p -154.2 -178.28 7.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.847 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -55.95 -38.49 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 73.52 111.161 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -89.11 -27.19 20.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 75.11 110.969 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 101.3 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 74.2 110.948 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -88.26 159.21 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.978 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.51 148.75 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 74.14 110.866 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.35 119.77 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 70.42 110.825 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.483 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 1.2 m-20 -50.16 162.32 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.611 0.72 . . . . 74.31 110.912 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.78 -10.86 11.73 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 -1.793 . . . . 74.21 112.303 0.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -48.92 103.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 64.53 110.895 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -98.81 149.79 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.34 110.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -83.83 154.39 23.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.05 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 p -98.36 -66.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.02 111.109 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -139.05 80.12 24.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 74.24 110.9 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -7.85 22.13 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.655 2.236 . . . . 74.14 112.294 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.46 -34.08 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 64.43 111.133 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.06 22.98 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 64.54 111.118 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.08 84.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.702 -0.761 . . . . 70.05 112.448 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.26 -156.25 12.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.738 . . . . 52.53 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -143.74 174.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.966 0.412 . . . . 74.32 111.087 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 36.5 m -92.41 144.8 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 41.12 110.857 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 72.42 111.143 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 71.22 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.34 161.24 21.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 53.35 111.068 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.78 152.52 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.55 110.938 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 178.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 73.01 110.928 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.92 21.79 10.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 72.03 112.512 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -128.74 155.26 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.356 . . . . 74.01 110.855 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.74 124.58 20.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.868 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.7 t -118.3 142.57 47.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 71.12 110.939 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.5 p -164.28 -179.32 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.91 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -51.72 -29.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.45 111.161 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -93.43 -36.62 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 75.23 110.934 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.55 89.82 8.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 72.42 110.95 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -64.13 152.37 40.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.952 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -127.06 139.93 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 60.34 110.877 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -100.89 119.96 39.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 64.51 110.835 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.473 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -51.84 163.11 0.68 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.627 0.727 . . . . 74.43 110.867 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.75 -10.45 11.49 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.623 -1.824 . . . . 75.31 112.389 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -47.37 104.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 74.4 110.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -102.06 138.71 38.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 62.22 110.811 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.3 m -75.58 150.35 38.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.809 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -98.87 -25.15 14.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 74.53 111.09 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 13.9 mp0 -154.52 86.73 3.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.519 0.676 . . . . 73.15 110.942 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.31 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.623 2.215 . . . . 72.33 112.408 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.51 7.68 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.3 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.36 10.62 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.186 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.81 99.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 22' ' ' GLN . . . -150.82 -155.98 7.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 75.0 112.562 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.56 -179.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 74.31 111.136 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.0 m -106.48 151.09 25.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 71.21 110.912 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 74.1 111.107 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.833 0.349 . . . . 52.55 110.918 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.49 156.62 23.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 71.41 111.097 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.929 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 177.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.87 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.66 22.73 8.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.674 -0.774 . . . . 54.41 112.462 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -131.91 162.84 29.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 65.35 110.877 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -56.7 148.77 19.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.957 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -148.81 145.05 27.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.878 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 p -164.26 177.57 8.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.788 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 m -49.82 -31.39 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 71.34 111.13 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.02 -36.74 14.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.93 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.44 96.26 10.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 53.21 110.865 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.54 152.46 39.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 72.31 110.918 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.77 147.54 45.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 54.02 110.909 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 114.04 26.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.9 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.12 161.09 0.38 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.539 0.685 . . . . 72.41 110.845 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.78 -10.44 11.55 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.63 -1.821 . . . . 74.1 112.299 -0.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -46.36 104.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 72.11 110.925 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -106.16 137.58 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 74.21 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 22.9 m -73.17 147.08 45.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.911 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -87.27 -50.59 6.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.13 111.134 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -149.36 68.71 9.41 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.567 0.699 . . . . 73.33 110.942 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.27 23.17 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.699 2.266 . . . . 74.44 112.348 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.89 -31.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 73.54 111.093 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.3 19.2 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 74.12 111.138 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 92.99 0.81 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.517 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.06 -160.36 8.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 44.11 112.528 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.37 176.07 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 74.22 111.123 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 10.8 m -103.96 156.71 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.887 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 64.14 111.114 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.756 0.312 . . . . 73.13 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.21 156.08 21.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.24 111.055 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.44 149.04 23.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.921 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.75 177.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 70.35 110.95 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.75 8.73 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.694 -0.765 . . . . 74.04 112.53 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.57 161.37 32.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 73.31 110.893 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.18 147.64 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 65.22 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.51 144.89 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 72.42 110.928 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 p -164.64 177.14 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.51 110.805 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -49.95 -31.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 75.14 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -89.87 -36.64 14.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 74.45 110.932 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 98.25 11.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.86 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 154.29 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 73.5 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -123.44 148.25 46.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 75.33 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 114.14 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.816 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.495 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.32 161.15 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 54.32 110.893 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.9 Cg_endo -69.75 -10.68 11.6 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.644 -1.815 . . . . 72.32 112.304 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.48 104.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.25 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -106.18 137.37 44.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.873 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 15.9 m -73.5 147.38 44.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -87.28 -56.45 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 71.02 111.126 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.53 69.45 20.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 75.24 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -8.22 23.05 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 71.01 112.345 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.86 -31.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 70.55 111.147 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.39 19.7 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.34 111.068 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 92.18 0.78 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.799 -0.715 . . . . 64.54 112.498 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.69 -159.73 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 74.13 112.407 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.79 174.82 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 74.23 111.159 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 8.7 m -103.1 156.19 17.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 53.54 110.984 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 74.32 111.054 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.769 0.319 . . . . 65.43 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.94 172.09 9.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 63.22 111.131 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -92.38 157.79 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 75.22 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -51.74 178.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.45 110.899 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.54 17.22 25.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 65.32 112.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -113.96 153.96 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 75.42 110.899 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -66.6 113.81 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 75.24 110.869 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -106.53 143.82 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 63.25 110.85 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -149.42 -177.92 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.825 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -58.71 -20.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 72.14 111.129 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.94 -50.39 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 74.22 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.82 129.98 36.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.963 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 163.16 31.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.873 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -114.84 177.89 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 63.03 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.02 140.36 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.515 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 3.0 m-20 -50.5 157.67 1.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 74.42 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -10.47 11.63 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.612 -1.828 . . . . 73.24 112.344 0.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -48.67 118.37 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 73.2 110.957 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -122.42 137.47 54.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.851 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 m -72.28 143.69 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.54 110.962 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -88.1 -60.21 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 71.25 111.126 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -143.3 73.52 17.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.562 0.696 . . . . 73.33 110.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -8.58 23.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.657 2.238 . . . . 64.01 112.356 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.79 -33.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 70.0 111.111 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.73 21.23 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.22 111.108 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 86.98 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 70.31 112.558 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.93 -158.51 10.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.711 -0.757 . . . . 63.31 112.492 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -144.42 174.87 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 65.23 111.104 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -101.5 151.12 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 65.41 110.899 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 53.45 111.053 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.851 0.358 . . . . 74.31 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.86 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 72.15 111.09 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -89.55 150.38 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 71.43 110.912 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 175.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.33 110.891 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.19 22.83 10.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 71.11 112.478 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -130.79 161.6 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 74.51 110.881 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -54.62 148.72 11.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.927 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.3 t -144.94 142.12 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.42 110.896 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 p -166.54 178.62 5.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 61.24 110.867 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.25 -31.97 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -90.04 -36.96 14.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 74.12 110.86 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.58 91.44 8.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 74.11 110.885 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 153.92 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 74.22 110.867 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -122.97 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.873 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.16 115.39 27.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.858 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.471 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -51.11 162.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 75.02 110.887 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.7 Cg_endo -69.72 -9.72 11.07 Favored 'Cis proline' 0 C--O 1.232 0.2 0 C-N-CA 122.722 -1.782 . . . . 64.5 112.302 -0.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.2 104.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 72.32 110.885 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -104.75 138.73 40.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 72.03 110.763 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 18.5 m -75.95 146.04 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.03 110.845 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -78.53 -53.21 7.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.507 . . . . 64.23 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.06 79.16 14.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 73.21 110.888 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 62.57 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.73 2.287 . . . . 71.23 112.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.3 p -166.91 -35.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 73.11 111.137 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.45 14.67 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.05 111.092 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.17 56.57 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.05 112.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.99 -164.49 37.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.531 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -137.77 174.57 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 74.12 111.162 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 m -100.68 159.11 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 64.14 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 64.44 111.112 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.886 0.374 . . . . 72.52 110.848 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 166.43 23.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.24 111.132 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.89 153.22 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 71.24 110.944 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 175.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.926 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.22 23.17 7.81 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 65.25 112.506 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -127.13 165.87 18.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 64.23 110.866 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -57.32 142.59 42.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.911 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -150.78 113.15 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.818 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -111.47 171.66 7.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.43 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.0 m -53.82 -25.31 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.14 111.115 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -89.72 -54.63 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.917 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pp -97.98 123.01 41.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 75.51 110.876 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -121.71 -172.3 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -120.62 -175.18 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.926 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.43 132.95 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.897 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.483 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -49.88 160.68 0.61 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 73.01 110.85 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.2 Cg_endo -69.8 -10.27 11.49 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.71 -1.788 . . . . 74.11 112.35 0.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -47.85 121.8 4.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 71.21 110.982 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -123.4 144.25 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.918 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 152.36 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.925 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -104.84 -22.02 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 63.12 111.108 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -179.53 76.37 0.19 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.582 0.706 . . . . 73.13 110.902 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -5.56 16.52 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 75.1 112.345 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.4 -31.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.119 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -115.31 20.49 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 74.01 111.096 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.2 62.38 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.78 -0.724 . . . . 64.54 112.488 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.85 -151.36 24.99 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.503 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 pt -139.71 -178.28 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 75.3 111.155 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.4 m -105.67 148.8 26.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 25.43 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.35 111.111 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.837 0.351 . . . . 72.15 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.13 155.93 24.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.12 111.074 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.57 159.51 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 73.24 110.904 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 167.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 70.53 110.909 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 47.26 31.86 6.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.493 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 159.48 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 62.12 110.898 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -48.84 149.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.934 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.3 t -150.39 141.24 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 64.23 110.916 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.3 p -165.09 174.5 10.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.956 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 m -51.16 -29.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 55.1 111.064 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.14 -38.92 13.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.967 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.78 106.66 18.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.53 110.912 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -81.01 158.44 25.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.913 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 t -121.17 146.14 47.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 73.41 110.933 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.1 115.36 30.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.21 160.59 0.42 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 72.41 110.819 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.0 Cg_endo -69.66 -11.62 11.75 Favored 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 -1.798 . . . . 71.0 112.369 -0.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -48.05 105.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.863 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -99.81 149.93 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.89 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.4 t -85.18 154.83 21.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -98.21 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 75.2 111.134 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -146.9 78.95 10.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 75.45 110.931 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -8.17 22.92 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.625 2.216 . . . . 71.41 112.33 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.69 -34.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 63.41 111.154 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.8 24.17 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.121 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.96 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.411 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.85 -153.73 11.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 72.11 112.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.46 174.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 75.44 111.148 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 86.8 m -96.08 144.33 26.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 54.22 110.88 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 65.24 111.173 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.838 0.352 . . . . 74.32 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.31 175.96 6.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 73.42 111.102 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.71 125.98 35.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 73.11 110.901 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -175.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.858 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.95 20.72 6.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.679 -0.772 . . . . 64.44 112.466 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -134.94 171.54 14.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 73.22 110.907 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.75 146.27 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.96 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.42 142.76 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 52.34 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -149.89 174.79 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 71.54 110.883 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.8 m -51.66 -28.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 70.43 111.132 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.76 -46.64 8.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.926 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.65 113.82 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 73.44 110.92 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -108.86 155.62 20.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 70.41 110.915 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 p -113.77 165.98 12.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 75.14 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 134.26 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.876 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.47 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -63.63 166.55 9.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 61.02 110.905 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.73 -14.51 12.44 Favored 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.723 -1.782 . . . . 71.14 112.332 0.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -48.21 116.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 71.31 110.954 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -117.88 146.78 43.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.844 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 13.8 m -70.01 147.56 49.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.882 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 p -85.89 -50.88 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.42 111.126 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -150.08 76.09 8.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.634 0.73 . . . . 75.33 110.971 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -7.67 21.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 52.54 112.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 -33.72 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 75.41 111.172 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.73 18.98 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.33 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.16 84.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 72.05 112.488 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.93 -156.08 9.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 75.55 112.448 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 pt -140.29 166.47 19.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 74.12 111.075 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 56.5 m -100.23 155.36 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 54.12 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 64.45 111.08 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.864 0.364 . . . . 71.13 110.869 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.51 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.51 111.127 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -89.47 158.41 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.5 110.985 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 171.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.905 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.37 4.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 75.45 112.474 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 157.93 44.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 72.44 110.884 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -48.46 149.73 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 74.24 110.889 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 t -150.73 140.28 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 53.04 110.937 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.7 p -165.12 174.25 10.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 72.41 110.862 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 m -50.63 -29.4 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 73.32 111.152 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -89.05 -38.35 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.933 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 105.57 17.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 74.12 110.942 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -77.32 158.93 29.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 63.15 110.903 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -126.62 145.03 50.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.884 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 117.07 33.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.962 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -51.0 162.54 0.58 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 74.12 110.886 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -11.03 11.89 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.669 -1.805 . . . . 72.31 112.318 0.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -49.07 104.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.907 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -98.85 151.84 20.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 75.11 110.856 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -78.71 160.99 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 71.14 110.856 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 -27.01 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 75.44 111.056 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -154.41 64.09 4.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 75.32 110.905 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.97 19.88 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.638 2.225 . . . . 73.42 112.354 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.25 -35.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.52 111.136 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.53 34.67 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 72.34 111.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.63 101.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.765 . . . . 63.01 112.461 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.61 -142.25 5.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.825 -0.702 . . . . 64.51 112.561 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.72 175.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 75.53 111.148 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.7 138.59 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.906 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.31 111.061 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 74.24 110.963 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 159.09 15.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.44 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.14 157.88 18.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 70.33 110.924 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.79 167.0 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.24 110.883 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 45.42 36.64 5.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 70.4 112.539 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.09 160.1 35.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.873 0.368 . . . . 62.01 110.895 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.86 149.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 72.33 110.883 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.3 t -150.38 141.8 23.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 74.4 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 100.0 p -154.2 -178.28 7.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 73.12 110.847 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -55.95 -38.49 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 73.52 111.161 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -89.11 -27.19 20.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 75.11 110.969 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 101.3 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 74.2 110.948 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -88.26 159.21 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.978 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.51 148.75 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 74.14 110.866 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.35 119.77 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 70.42 110.825 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.483 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 1.2 m-20 -50.16 162.32 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.611 0.72 . . . . 74.31 110.912 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.78 -10.86 11.73 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 -1.793 . . . . 74.21 112.303 0.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -48.92 103.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 64.53 110.895 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -98.81 149.79 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.34 110.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -83.83 154.39 23.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.05 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 p -98.36 -66.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 73.02 111.109 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -139.05 80.12 24.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 74.24 110.9 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -7.85 22.13 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.655 2.236 . . . . 74.14 112.294 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -85.46 -34.08 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 64.43 111.133 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -114.06 22.98 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 64.54 111.118 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.08 84.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.702 -0.761 . . . . 70.05 112.448 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.26 -156.25 12.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.738 . . . . 52.53 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -143.74 174.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.966 0.412 . . . . 74.32 111.087 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 36.5 m -92.41 144.8 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 41.12 110.857 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 72.42 111.143 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 71.22 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.34 161.24 21.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 53.35 111.068 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.78 152.52 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.55 110.938 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 178.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 73.01 110.928 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.92 21.79 10.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 72.03 112.512 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -128.74 155.26 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.356 . . . . 74.01 110.855 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -60.74 124.58 20.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.868 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.7 t -118.3 142.57 47.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 71.12 110.939 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.5 p -164.28 -179.32 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.91 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -51.72 -29.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.45 111.161 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -93.43 -36.62 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 75.23 110.934 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.55 89.82 8.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 72.42 110.95 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -64.13 152.37 40.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.952 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -127.06 139.93 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 60.34 110.877 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -100.89 119.96 39.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 64.51 110.835 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -51.84 163.11 0.68 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.627 0.727 . . . . 74.43 110.867 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.75 -10.45 11.49 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.623 -1.824 . . . . 75.31 112.389 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -47.37 104.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 74.4 110.92 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -102.06 138.71 38.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 62.22 110.811 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.3 m -75.58 150.35 38.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.809 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -98.87 -25.15 14.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 74.53 111.09 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 13.9 mp0 -154.52 86.73 3.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.519 0.676 . . . . 73.15 110.942 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.31 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.623 2.215 . . . . 72.33 112.408 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -100.51 7.68 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.3 111.148 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.36 10.62 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.186 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.81 99.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 22' ' ' GLN . . . -150.82 -155.98 7.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 75.0 112.562 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.56 -179.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 74.31 111.136 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.0 m -106.48 151.09 25.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 71.21 110.912 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 74.1 111.107 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.833 0.349 . . . . 52.55 110.918 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.49 156.62 23.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.13 111.097 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.929 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 177.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.87 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.66 22.73 8.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.674 -0.774 . . . . 54.41 112.462 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.2 mm-40 -131.91 162.84 29.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 54.4 110.877 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' HA ' HG22 ' A' ' 28' ' ' ILE . 48.6 t80 -56.7 148.77 19.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.957 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -148.81 145.05 27.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.878 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 p -164.26 177.57 8.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.788 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 m -49.82 -31.39 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 61.33 111.13 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.02 -36.74 14.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.22 110.93 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.44 96.26 10.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 52.45 110.865 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.54 152.46 39.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.13 110.918 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.77 147.54 45.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 54.02 110.909 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 114.04 26.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 33.22 110.9 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.12 161.09 0.38 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.539 0.685 . . . . 72.41 110.845 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.78 -10.44 11.55 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.63 -1.821 . . . . 74.1 112.299 -0.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -46.36 104.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 71.13 110.925 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -106.16 137.58 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 74.04 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 22.9 m -73.17 147.08 45.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 61.32 110.911 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -87.27 -50.59 6.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 70.43 111.134 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -149.36 68.71 9.41 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.567 0.699 . . . . 73.33 110.942 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.27 23.17 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.699 2.266 . . . . 42.52 112.348 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.797 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.89 -31.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 73.54 111.093 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.797 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -120.3 19.2 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.138 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 92.99 0.81 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 73.53 112.517 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.06 -160.36 8.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 35.21 112.528 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -138.37 176.07 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 74.22 111.123 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 10.8 m -103.96 156.71 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.887 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 64.14 111.114 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.756 0.312 . . . . 73.13 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.21 156.08 21.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 72.11 111.055 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.44 149.04 23.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.921 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.75 177.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 70.35 110.95 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.75 8.73 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.694 -0.765 . . . . 74.04 112.53 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.57 161.37 32.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 73.31 110.893 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.18 147.64 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 63.42 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.51 144.89 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 72.42 110.928 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 p -164.64 177.14 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.51 110.805 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -49.95 -31.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 64.45 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -89.87 -36.64 14.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 74.45 110.932 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 98.25 11.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.86 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 154.29 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 60.24 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -123.44 148.25 46.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 70.04 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 114.14 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.816 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.32 161.15 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 54.32 110.893 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.9 Cg_endo -69.75 -10.68 11.6 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.644 -1.815 . . . . 72.32 112.304 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.48 104.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.25 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -106.18 137.37 44.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.873 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 15.9 m -73.5 147.38 44.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -87.28 -56.45 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 64.42 111.126 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.53 69.45 20.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 75.24 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -8.22 23.05 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 65.22 112.345 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.86 -31.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 70.55 111.147 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.788 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -120.39 19.7 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.13 111.068 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 92.18 0.78 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.799 -0.715 . . . . 64.54 112.498 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.69 -159.73 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 62.14 112.407 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.79 174.82 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.34 111.159 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 8.7 m -103.1 156.19 17.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 53.54 110.984 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 74.32 111.054 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.769 0.319 . . . . 65.43 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.94 172.09 9.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.4 111.131 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -92.38 157.79 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.3 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -51.74 178.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.899 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.54 17.22 25.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 24.23 112.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -113.96 153.96 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 75.03 110.899 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 28' ' ' ILE . 4.4 t80 -66.6 113.81 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 75.24 110.869 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -106.53 143.82 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 63.25 110.85 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -149.42 -177.92 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.825 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -58.71 -20.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 72.14 111.129 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.94 -50.39 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.82 129.98 36.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 63.43 110.963 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 163.16 31.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 64.34 110.873 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -114.84 177.89 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 63.03 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.02 140.36 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 3.0 m-20 -50.5 157.67 1.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 55.42 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -10.47 11.63 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.612 -1.828 . . . . 73.24 112.344 0.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -48.67 118.37 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 61.42 110.957 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -122.42 137.47 54.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.851 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 m -72.28 143.69 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.54 110.962 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -88.1 -60.21 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 71.25 111.126 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -143.3 73.52 17.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.562 0.696 . . . . 73.33 110.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -8.58 23.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.657 2.238 . . . . 64.01 112.356 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 25' ' ' ILE . 7.6 p -82.79 -33.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 55.41 111.111 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -116.73 21.23 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.22 111.108 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 86.98 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 54.44 112.558 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.93 -158.51 10.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.711 -0.757 . . . . 61.11 112.492 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -144.42 174.87 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 44.11 111.104 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -101.5 151.12 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 65.41 110.899 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 53.45 111.053 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.851 0.358 . . . . 74.31 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.86 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 33.25 111.09 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -89.55 150.38 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 71.43 110.912 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 175.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.891 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.19 22.83 10.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 52.32 112.478 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.9 mm-40 -130.79 161.6 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 74.51 110.881 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' ILE . 55.7 t80 -54.62 148.72 11.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 70.13 110.927 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.3 t -144.94 142.12 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.42 110.896 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 p -166.54 178.62 5.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 61.24 110.867 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.25 -31.97 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -90.04 -36.96 14.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.86 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.402 HD13 ' HD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.58 91.44 8.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 30.35 110.885 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 153.92 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 61.12 110.867 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -122.97 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 60.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.16 115.39 27.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.858 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.481 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -51.11 162.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 75.02 110.887 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.7 Cg_endo -69.72 -9.72 11.07 Favored 'Cis proline' 0 C--O 1.232 0.2 0 C-N-CA 122.722 -1.782 . . . . 64.14 112.302 -0.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.2 104.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 60.44 110.885 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -104.75 138.73 40.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 54.22 110.763 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 18.5 m -75.95 146.04 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.03 110.845 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -78.53 -53.21 7.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.507 . . . . 62.41 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.06 79.16 14.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 73.21 110.888 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 62.57 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.73 2.287 . . . . 54.2 112.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG23 ' A' ' 25' ' ' ILE . 5.3 p -166.91 -35.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 61.03 111.137 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.806 HG23 HG13 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -106.45 14.67 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.52 111.092 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.17 56.57 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 63.52 112.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.99 -164.49 37.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.531 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -137.77 174.57 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 63.11 111.162 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 m -100.68 159.11 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 63.32 111.112 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.886 0.374 . . . . 72.52 110.848 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 166.43 23.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.32 111.132 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.89 153.22 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 61.02 110.944 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 175.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.13 110.926 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.22 23.17 7.81 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 65.25 112.506 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -127.13 165.87 18.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 52.24 110.866 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.451 ' CD2' HD11 ' A' ' 12' ' ' LEU . 73.0 t80 -57.32 142.59 42.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.911 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' LEU . 3.8 t -150.78 113.15 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.818 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -111.47 171.66 7.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.43 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.0 m -53.82 -25.31 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 51.24 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -89.72 -54.63 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.917 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 7' ' ' TYR . 1.3 pp -97.98 123.01 41.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 75.51 110.876 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -121.71 -172.3 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -120.62 -175.18 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 54.02 110.926 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.43 132.95 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.897 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -49.88 160.68 0.61 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.21 110.85 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.2 Cg_endo -69.8 -10.27 11.49 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.71 -1.788 . . . . 74.11 112.35 0.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -47.85 121.8 4.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 64.41 110.982 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -123.4 144.25 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.918 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 152.36 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.925 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -104.84 -22.02 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 63.12 111.108 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -179.53 76.37 0.19 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.582 0.706 . . . . 72.11 110.902 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.79 -5.56 16.52 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 70.0 112.345 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.677 HG13 HG23 ' A' ' 25' ' ' ILE . 10.7 p -83.4 -31.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 64.14 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -115.31 20.49 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 62.05 111.096 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.2 62.38 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.78 -0.724 . . . . 64.54 112.488 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.85 -151.36 24.99 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.503 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.3 pt -139.71 -178.28 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 75.3 111.155 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.4 m -105.67 148.8 26.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 14.42 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.35 111.111 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.837 0.351 . . . . 64.11 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 12' ' ' LEU . . . -113.13 155.93 24.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.35 111.074 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.57 159.51 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 72.3 110.904 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.87 167.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 62.41 110.909 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 47.26 31.86 6.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.493 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 159.48 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 51.24 110.898 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -48.84 149.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.934 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.3 t -150.39 141.24 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 64.23 110.916 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.3 p -165.09 174.5 10.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.956 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 m -51.16 -29.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 54.34 111.064 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.14 -38.92 13.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.967 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -89.78 106.66 18.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.912 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -81.01 158.44 25.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.913 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 t -121.17 146.14 47.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 73.41 110.933 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.1 115.36 30.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.14 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.21 160.59 0.42 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 72.41 110.819 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.0 Cg_endo -69.66 -11.62 11.75 Favored 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 -1.798 . . . . 71.0 112.369 -0.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.6 m-85 -48.05 105.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 71.4 110.863 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -99.81 149.93 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.89 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.4 t -85.18 154.83 21.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -98.21 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 64.32 111.134 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -146.9 78.95 10.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 63.22 110.931 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -8.17 22.92 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.625 2.216 . . . . 54.32 112.33 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -85.69 -34.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 63.41 111.154 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.661 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -113.8 24.17 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.24 111.121 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.96 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.411 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.85 -153.73 11.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 72.11 112.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.46 174.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 75.44 111.148 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 86.8 m -96.08 144.33 26.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 54.22 110.88 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 42.12 111.173 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.838 0.352 . . . . 74.32 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.31 175.96 6.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 45.14 111.102 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.71 125.98 35.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 73.11 110.901 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -55.99 -175.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 71.42 110.858 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.95 20.72 6.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.679 -0.772 . . . . 34.31 112.466 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.589 ' C ' HG22 ' A' ' 28' ' ' ILE . 1.8 mt-10 -134.94 171.54 14.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 73.22 110.907 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.75 146.27 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.96 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.42 142.76 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 52.34 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -149.89 174.79 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 71.54 110.883 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.8 m -51.66 -28.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 65.45 111.132 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.76 -46.64 8.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.926 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.65 113.82 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 65.14 110.92 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -108.86 155.62 20.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.1 110.915 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 p -113.77 165.98 12.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 71.11 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 134.26 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 54.31 110.876 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -63.63 166.55 9.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 61.02 110.905 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.73 -14.51 12.44 Favored 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.723 -1.782 . . . . 71.14 112.332 0.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 4' ' ' LYS . 12.0 m-85 -48.21 116.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 70.01 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -117.88 146.78 43.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.844 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 13.8 m -70.01 147.56 49.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.882 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 p -85.89 -50.88 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.41 111.126 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -150.08 76.09 8.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.634 0.73 . . . . 75.33 110.971 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -7.67 21.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 51.02 112.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 25' ' ' ILE . 7.5 p -84.15 -33.72 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 51.13 111.172 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.741 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.73 18.98 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.33 111.128 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.16 84.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 72.05 112.488 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.93 -156.08 9.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 70.0 112.448 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.589 HG22 ' C ' ' A' ' 6' ' ' GLU . 1.2 pt -140.29 166.47 19.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 74.12 111.075 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 56.5 m -100.23 155.36 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 54.12 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 63.0 111.08 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.864 0.364 . . . . 71.13 110.869 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.51 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.51 111.127 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -89.47 158.41 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 74.01 110.985 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -55.82 171.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.905 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.37 4.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 55.43 112.474 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 157.93 44.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 72.44 110.884 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -48.46 149.73 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.1 110.889 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 t -150.73 140.28 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 53.04 110.937 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 51.7 p -165.12 174.25 10.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.55 110.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.7 m -50.63 -29.4 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.32 111.152 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -89.05 -38.35 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.933 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 105.57 17.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 61.43 110.942 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -77.32 158.93 29.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 54.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -126.62 145.03 50.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.884 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 117.07 33.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 70.12 110.962 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -51.0 162.54 0.58 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 74.12 110.886 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -11.03 11.89 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.669 -1.805 . . . . 54.33 112.318 0.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -49.07 104.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.907 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -98.85 151.84 20.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 75.11 110.856 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -78.71 160.99 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 71.14 110.856 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 -27.01 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 62.33 111.056 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 25' ' ' ILE . 33.9 mt-30 -154.41 64.09 4.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 70.51 110.905 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.8 -6.97 19.88 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.638 2.225 . . . . 14.23 112.354 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -99.25 -35.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.52 111.136 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -118.53 34.67 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.51 111.171 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.63 101.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.765 . . . . 63.01 112.461 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.61 -142.25 5.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.825 -0.702 . . . . 53.13 112.561 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.72 175.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 74.24 111.148 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 97.7 m -101.7 138.59 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.906 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.061 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 71.54 110.963 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 159.09 15.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.14 157.88 18.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 62.11 110.924 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.79 167.0 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 70.51 110.883 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 45.42 36.64 5.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 70.4 112.539 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' HG22 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -131.09 160.1 35.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.873 0.368 . . . . 62.01 110.895 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.86 149.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 72.33 110.883 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.3 t -150.38 141.8 23.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 74.4 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 100.0 p -154.2 -178.28 7.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.21 110.847 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -55.95 -38.49 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 73.2 111.161 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -89.11 -27.19 20.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 75.11 110.969 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 101.3 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 74.2 110.948 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -88.26 159.21 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.978 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.51 148.75 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 74.14 110.866 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.35 119.77 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 52.32 110.825 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 1.2 m-20 -50.16 162.32 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.611 0.72 . . . . 74.31 110.912 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.78 -10.86 11.73 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 -1.793 . . . . 64.51 112.303 0.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -48.92 103.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 64.15 110.895 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -98.81 149.79 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.34 110.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -83.83 154.39 23.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.05 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 p -98.36 -66.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 62.25 111.109 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -139.05 80.12 24.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 74.24 110.9 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -7.85 22.13 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.655 2.236 . . . . 74.14 112.294 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG23 ' A' ' 25' ' ' ILE . 7.7 p -85.46 -34.08 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 45.53 111.133 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.712 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.06 22.98 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 64.54 111.118 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.08 84.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.702 -0.761 . . . . 41.45 112.448 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.26 -156.25 12.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.738 . . . . 52.53 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -143.74 174.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.966 0.412 . . . . 74.32 111.087 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 36.5 m -92.41 144.8 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 41.12 110.857 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 72.42 111.143 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 71.22 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.34 161.24 21.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 53.35 111.068 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.78 152.52 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.44 110.938 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 178.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 71.21 110.928 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.92 21.79 10.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 72.03 112.512 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -128.74 155.26 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.356 . . . . 74.01 110.855 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.696 ' O ' HD22 ' A' ' 12' ' ' LEU . 38.9 t80 -60.74 124.58 20.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.868 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.7 t -118.3 142.57 47.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 71.12 110.939 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.5 p -164.28 -179.32 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 72.23 110.91 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -51.72 -29.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.45 111.161 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -93.43 -36.62 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 75.23 110.934 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -89.55 89.82 8.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 72.14 110.95 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -64.13 152.37 40.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.43 110.952 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -127.06 139.93 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 60.23 110.877 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -100.89 119.96 39.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 64.51 110.835 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -51.84 163.11 0.68 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.627 0.727 . . . . 70.03 110.867 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.75 -10.45 11.49 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.623 -1.824 . . . . 75.31 112.389 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.8 m-85 -47.37 104.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 74.4 110.92 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -102.06 138.71 38.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 62.22 110.811 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.3 m -75.58 150.35 38.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.809 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -98.87 -25.15 14.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 63.31 111.09 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.507 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 13.9 mp0 -154.52 86.73 3.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.519 0.676 . . . . 73.15 110.942 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.31 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.623 2.215 . . . . 72.33 112.408 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.698 HG13 HD13 ' A' ' 25' ' ' ILE . 8.0 p -100.51 7.68 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.3 111.148 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.698 HD13 HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -124.36 10.62 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.186 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.81 99.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 22' ' ' GLN . . . -150.82 -155.98 7.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 75.0 112.562 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -137.56 -179.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 74.31 111.136 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 24.0 m -106.48 151.09 25.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.912 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 74.1 111.107 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.833 0.349 . . . . 52.55 110.918 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.49 156.62 23.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.13 111.097 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.929 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 177.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.87 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.66 22.73 8.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.674 -0.774 . . . . 54.41 112.462 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.2 mm-40 -131.91 162.84 29.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 54.4 110.877 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' HA ' HG22 ' A' ' 28' ' ' ILE . 48.6 t80 -56.7 148.77 19.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.957 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -148.81 145.05 27.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.878 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 p -164.26 177.57 8.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.788 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 m -49.82 -31.39 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 61.33 111.13 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.02 -36.74 14.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.22 110.93 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.44 96.26 10.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 52.45 110.865 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.54 152.46 39.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.13 110.918 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.77 147.54 45.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 54.02 110.909 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 114.04 26.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 33.22 110.9 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.12 161.09 0.38 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.539 0.685 . . . . 72.41 110.845 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.78 -10.44 11.55 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.63 -1.821 . . . . 74.1 112.299 -0.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -46.36 104.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 71.13 110.925 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -106.16 137.58 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 74.04 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 22.9 m -73.17 147.08 45.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 61.32 110.911 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -87.27 -50.59 6.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 70.43 111.134 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -149.36 68.71 9.41 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.567 0.699 . . . . 73.33 110.942 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.27 23.17 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.699 2.266 . . . . 42.52 112.348 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.797 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.89 -31.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 73.54 111.093 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.797 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -120.3 19.2 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 71.55 111.138 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 92.99 0.81 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 73.53 112.517 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.06 -160.36 8.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 35.21 112.528 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -138.37 176.07 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 74.22 111.123 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 10.8 m -103.96 156.71 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.887 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 64.14 111.114 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.756 0.312 . . . . 73.13 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.21 156.08 21.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 72.11 111.055 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.44 149.04 23.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.921 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.75 177.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 70.35 110.95 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.75 8.73 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.694 -0.765 . . . . 74.04 112.53 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.57 161.37 32.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 73.31 110.893 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.18 147.64 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 63.42 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.51 144.89 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 72.42 110.928 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 p -164.64 177.14 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.51 110.805 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -49.95 -31.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 64.45 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -89.87 -36.64 14.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 74.45 110.932 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 98.25 11.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 65.33 110.86 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 154.29 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 60.24 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -123.44 148.25 46.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 70.04 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 114.14 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.816 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.32 161.15 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 54.32 110.893 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.9 Cg_endo -69.75 -10.68 11.6 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.644 -1.815 . . . . 72.32 112.304 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.48 104.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.25 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -106.18 137.37 44.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.873 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 15.9 m -73.5 147.38 44.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -87.28 -56.45 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 64.42 111.126 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.53 69.45 20.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 75.24 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -8.22 23.05 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 65.22 112.345 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.86 -31.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 70.55 111.147 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.788 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -120.39 19.7 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.13 111.068 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 92.18 0.78 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.799 -0.715 . . . . 64.54 112.498 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.69 -159.73 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 62.14 112.407 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.79 174.82 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.34 111.159 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 8.7 m -103.1 156.19 17.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 53.54 110.984 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 74.32 111.054 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.769 0.319 . . . . 65.43 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.94 172.09 9.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.4 111.131 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -92.38 157.79 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.3 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -51.74 178.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.899 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.54 17.22 25.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 24.23 112.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -113.96 153.96 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 75.03 110.899 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 28' ' ' ILE . 4.4 t80 -66.6 113.81 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 75.24 110.869 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -106.53 143.82 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 63.25 110.85 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -149.42 -177.92 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 64.22 110.825 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -58.71 -20.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 72.14 111.129 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.94 -50.39 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.82 129.98 36.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 63.43 110.963 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 163.16 31.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 64.34 110.873 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -114.84 177.89 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 63.03 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.02 140.36 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 64.44 110.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 3.0 m-20 -50.5 157.67 1.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 55.42 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -10.47 11.63 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.612 -1.828 . . . . 73.24 112.344 0.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -48.67 118.37 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 61.42 110.957 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -122.42 137.47 54.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.851 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 m -72.28 143.69 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.54 110.962 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -88.1 -60.21 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 71.25 111.126 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -143.3 73.52 17.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.562 0.696 . . . . 73.33 110.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -8.58 23.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.657 2.238 . . . . 64.01 112.356 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 25' ' ' ILE . 7.6 p -82.79 -33.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 55.41 111.111 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -116.73 21.23 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.22 111.108 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 86.98 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 54.44 112.558 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.93 -158.51 10.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.711 -0.757 . . . . 61.11 112.492 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -144.42 174.87 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 44.11 111.104 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -101.5 151.12 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 65.41 110.899 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 53.45 111.053 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.851 0.358 . . . . 74.31 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.86 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 33.25 111.09 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -89.55 150.38 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 71.43 110.912 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 175.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.891 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.19 22.83 10.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 52.32 112.478 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.9 mm-40 -130.79 161.6 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 74.51 110.881 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' ILE . 55.7 t80 -54.62 148.72 11.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 70.13 110.927 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.3 t -144.94 142.12 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.42 110.896 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 p -166.54 178.62 5.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 61.24 110.867 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.25 -31.97 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 74.22 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -90.04 -36.96 14.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 72.15 110.86 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.402 HD13 ' HD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.58 91.44 8.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 30.35 110.885 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 153.92 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 61.12 110.867 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -122.97 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 60.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.16 115.39 27.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.858 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.481 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -51.11 162.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 75.02 110.887 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.7 Cg_endo -69.72 -9.72 11.07 Favored 'Cis proline' 0 C--O 1.232 0.2 0 C-N-CA 122.722 -1.782 . . . . 64.14 112.302 -0.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.2 104.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 60.44 110.885 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -104.75 138.73 40.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 54.22 110.763 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 18.5 m -75.95 146.04 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.03 110.845 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -78.53 -53.21 7.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.507 . . . . 62.41 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.06 79.16 14.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 73.21 110.888 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 62.57 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.73 2.287 . . . . 54.2 112.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG23 ' A' ' 25' ' ' ILE . 5.3 p -166.91 -35.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 61.03 111.137 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.806 HG23 HG13 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -106.45 14.67 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.52 111.092 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.17 56.57 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 63.52 112.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.99 -164.49 37.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 61.33 112.531 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -137.77 174.57 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 63.11 111.162 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 m -100.68 159.11 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.33 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 63.32 111.112 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.886 0.374 . . . . 72.52 110.848 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 166.43 23.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.32 111.132 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.89 153.22 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 61.02 110.944 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 175.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.13 110.926 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.22 23.17 7.81 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 65.25 112.506 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -127.13 165.87 18.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 52.24 110.866 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.451 ' CD2' HD11 ' A' ' 12' ' ' LEU . 73.0 t80 -57.32 142.59 42.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.911 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' LEU . 3.8 t -150.78 113.15 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.818 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -111.47 171.66 7.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.43 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.0 m -53.82 -25.31 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 51.24 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -89.72 -54.63 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.917 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 7' ' ' TYR . 1.3 pp -97.98 123.01 41.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 75.51 110.876 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -121.71 -172.3 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -120.62 -175.18 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 54.02 110.926 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.43 132.95 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.897 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -49.88 160.68 0.61 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.21 110.85 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.2 Cg_endo -69.8 -10.27 11.49 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.71 -1.788 . . . . 74.11 112.35 0.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -47.85 121.8 4.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 64.41 110.982 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -123.4 144.25 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.918 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 152.36 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.925 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -104.84 -22.02 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 63.12 111.108 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -179.53 76.37 0.19 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.582 0.706 . . . . 72.11 110.902 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.79 -5.56 16.52 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 70.0 112.345 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.677 HG13 HG23 ' A' ' 25' ' ' ILE . 10.7 p -83.4 -31.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 64.14 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -115.31 20.49 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 62.05 111.096 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.2 62.38 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.78 -0.724 . . . . 64.54 112.488 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.85 -151.36 24.99 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 75.43 112.503 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.3 pt -139.71 -178.28 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 75.3 111.155 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.4 m -105.67 148.8 26.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 14.42 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.35 111.111 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.837 0.351 . . . . 64.11 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 12' ' ' LEU . . . -113.13 155.93 24.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.35 111.074 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.57 159.51 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 72.3 110.904 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.87 167.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 62.41 110.909 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 47.26 31.86 6.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.493 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 159.48 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 51.24 110.898 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -48.84 149.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.53 110.934 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.3 t -150.39 141.24 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 64.23 110.916 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.3 p -165.09 174.5 10.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.956 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 m -51.16 -29.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 54.34 111.064 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.14 -38.92 13.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.967 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -89.78 106.66 18.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.24 110.912 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -81.01 158.44 25.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.02 110.913 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 t -121.17 146.14 47.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 73.41 110.933 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.1 115.36 30.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.14 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.21 160.59 0.42 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 72.41 110.819 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.0 Cg_endo -69.66 -11.62 11.75 Favored 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 -1.798 . . . . 71.0 112.369 -0.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.6 m-85 -48.05 105.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 71.4 110.863 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -99.81 149.93 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 74.54 110.89 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.4 t -85.18 154.83 21.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -98.21 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 64.32 111.134 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -146.9 78.95 10.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 63.22 110.931 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -8.17 22.92 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.625 2.216 . . . . 54.32 112.33 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -85.69 -34.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 63.41 111.154 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.661 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -113.8 24.17 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.24 111.121 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.96 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.411 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.85 -153.73 11.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 72.11 112.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.46 174.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 75.44 111.148 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 86.8 m -96.08 144.33 26.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 54.22 110.88 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 42.12 111.173 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.838 0.352 . . . . 74.32 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.31 175.96 6.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 45.14 111.102 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.71 125.98 35.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 73.11 110.901 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -55.99 -175.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 71.42 110.858 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.95 20.72 6.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.679 -0.772 . . . . 34.31 112.466 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.589 ' C ' HG22 ' A' ' 28' ' ' ILE . 1.8 mt-10 -134.94 171.54 14.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 73.22 110.907 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.75 146.27 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.96 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.42 142.76 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 52.34 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -149.89 174.79 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 71.54 110.883 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.8 m -51.66 -28.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 65.45 111.132 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.76 -46.64 8.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.926 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.65 113.82 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 65.14 110.92 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -108.86 155.62 20.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.1 110.915 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 p -113.77 165.98 12.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 71.11 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 134.26 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 54.31 110.876 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -63.63 166.55 9.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 61.02 110.905 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.73 -14.51 12.44 Favored 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.723 -1.782 . . . . 71.14 112.332 0.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 4' ' ' LYS . 12.0 m-85 -48.21 116.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 70.01 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -117.88 146.78 43.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.844 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 13.8 m -70.01 147.56 49.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.882 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 p -85.89 -50.88 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.41 111.126 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -150.08 76.09 8.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.634 0.73 . . . . 75.33 110.971 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -7.67 21.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 51.02 112.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 25' ' ' ILE . 7.5 p -84.15 -33.72 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 51.13 111.172 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.741 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.73 18.98 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.33 111.128 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.16 84.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 72.05 112.488 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.93 -156.08 9.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 70.0 112.448 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.589 HG22 ' C ' ' A' ' 6' ' ' GLU . 1.2 pt -140.29 166.47 19.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 74.12 111.075 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 56.5 m -100.23 155.36 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 54.12 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 63.0 111.08 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.864 0.364 . . . . 71.13 110.869 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.51 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.51 111.127 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -89.47 158.41 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 74.01 110.985 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -55.82 171.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.43 110.905 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.37 4.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 55.43 112.474 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 157.93 44.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 72.44 110.884 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -48.46 149.73 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.1 110.889 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 t -150.73 140.28 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 53.04 110.937 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 51.7 p -165.12 174.25 10.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.55 110.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.7 m -50.63 -29.4 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.32 111.152 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -89.05 -38.35 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.54 110.933 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 105.57 17.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 61.43 110.942 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -77.32 158.93 29.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 54.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -126.62 145.03 50.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.884 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 117.07 33.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 70.12 110.962 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -51.0 162.54 0.58 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 74.12 110.886 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -11.03 11.89 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.669 -1.805 . . . . 54.33 112.318 0.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -49.07 104.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.907 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -98.85 151.84 20.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 75.11 110.856 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -78.71 160.99 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 71.14 110.856 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 -27.01 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 62.33 111.056 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 25' ' ' ILE . 33.9 mt-30 -154.41 64.09 4.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 70.51 110.905 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.8 -6.97 19.88 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.638 2.225 . . . . 14.23 112.354 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -99.25 -35.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.52 111.136 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -118.53 34.67 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.51 111.171 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.63 101.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.765 . . . . 63.01 112.461 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.61 -142.25 5.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.825 -0.702 . . . . 53.13 112.561 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.72 175.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 74.24 111.148 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 97.7 m -101.7 138.59 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 72.34 110.906 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.03 111.061 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 71.54 110.963 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 159.09 15.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 73.32 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.14 157.88 18.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 62.11 110.924 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.79 167.0 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 70.51 110.883 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 45.42 36.64 5.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 70.4 112.539 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' HG22 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -131.09 160.1 35.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.873 0.368 . . . . 62.01 110.895 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.86 149.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 72.33 110.883 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.3 t -150.38 141.8 23.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 74.4 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 100.0 p -154.2 -178.28 7.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.21 110.847 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -55.95 -38.49 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 73.2 111.161 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -89.11 -27.19 20.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 75.11 110.969 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 101.3 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 74.2 110.948 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -88.26 159.21 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.24 110.978 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.51 148.75 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 74.14 110.866 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.35 119.77 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 52.32 110.825 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 1.2 m-20 -50.16 162.32 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.611 0.72 . . . . 74.31 110.912 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.78 -10.86 11.73 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 -1.793 . . . . 64.51 112.303 0.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -48.92 103.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 64.15 110.895 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -98.81 149.79 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.34 110.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -83.83 154.39 23.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.05 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 p -98.36 -66.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 62.25 111.109 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -139.05 80.12 24.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 74.24 110.9 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -7.85 22.13 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.655 2.236 . . . . 74.14 112.294 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG23 ' A' ' 25' ' ' ILE . 7.7 p -85.46 -34.08 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 45.53 111.133 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.712 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.06 22.98 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 64.54 111.118 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.08 84.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.702 -0.761 . . . . 41.45 112.448 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.26 -156.25 12.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.738 . . . . 52.53 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -143.74 174.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.966 0.412 . . . . 74.32 111.087 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 36.5 m -92.41 144.8 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 41.12 110.857 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 72.42 111.143 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 71.22 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.34 161.24 21.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 53.35 111.068 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.78 152.52 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.44 110.938 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 178.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 71.21 110.928 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.92 21.79 10.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 72.03 112.512 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -128.74 155.26 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.356 . . . . 74.01 110.855 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.696 ' O ' HD22 ' A' ' 12' ' ' LEU . 38.9 t80 -60.74 124.58 20.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 74.22 110.868 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.7 t -118.3 142.57 47.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 71.12 110.939 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.5 p -164.28 -179.32 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 72.23 110.91 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -51.72 -29.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.45 111.161 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -93.43 -36.62 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 75.23 110.934 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -89.55 89.82 8.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 72.14 110.95 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -64.13 152.37 40.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.43 110.952 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -127.06 139.93 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 60.23 110.877 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -100.89 119.96 39.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 64.51 110.835 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -51.84 163.11 0.68 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.627 0.727 . . . . 70.03 110.867 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.75 -10.45 11.49 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.623 -1.824 . . . . 75.31 112.389 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.8 m-85 -47.37 104.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 74.4 110.92 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -102.06 138.71 38.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 62.22 110.811 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.3 m -75.58 150.35 38.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.41 110.809 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -98.87 -25.15 14.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 63.31 111.09 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.507 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 13.9 mp0 -154.52 86.73 3.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.519 0.676 . . . . 73.15 110.942 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.31 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.623 2.215 . . . . 72.33 112.408 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.698 HG13 HD13 ' A' ' 25' ' ' ILE . 8.0 p -100.51 7.68 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.3 111.148 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.698 HD13 HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -124.36 10.62 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.186 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.81 99.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 22' ' ' GLN . . . -150.82 -155.98 7.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 75.0 112.562 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -137.56 -179.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 74.31 111.136 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 24.0 m -106.48 151.09 25.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.912 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 74.1 111.107 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.833 0.349 . . . . 52.549999999999997 110.918 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.49 156.62 23.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.129999999999995 111.097 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 72.329999999999998 110.929 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 177.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.87 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.66 22.73 8.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.674 -0.774 . . . . 54.409999999999997 112.462 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.2 mm-40 -131.91 162.84 29.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 54.399999999999999 110.877 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' HA ' HG22 ' A' ' 28' ' ' ILE . 48.6 t80 -56.7 148.77 19.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.957 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -148.81 145.05 27.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 72.299999999999997 110.878 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 p -164.26 177.57 8.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 73.420000000000002 110.788 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 m -49.82 -31.39 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 111.13 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.02 -36.74 14.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.93 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.44 96.26 10.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 52.450000000000003 110.865 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.54 152.46 39.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.129999999999995 110.918 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.77 147.54 45.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 54.020000000000003 110.909 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 114.04 26.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 33.219999999999999 110.9 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.12 161.09 0.38 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.539 0.685 . . . . 72.409999999999997 110.845 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.78 -10.44 11.55 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.63 -1.821 . . . . 74.099999999999994 112.299 -0.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -46.36 104.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 71.129999999999995 110.925 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -106.16 137.58 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 22.9 m -73.17 147.08 45.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 61.32 110.911 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -87.27 -50.59 6.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 70.430000000000007 111.134 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -149.36 68.71 9.41 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.567 0.699 . . . . 73.329999999999998 110.942 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.27 23.17 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.699 2.266 . . . . 42.520000000000003 112.348 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.797 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.89 -31.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 73.540000000000006 111.093 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.797 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -120.3 19.2 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 71.549999999999997 111.138 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 92.99 0.81 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 73.530000000000001 112.517 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.06 -160.36 8.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 35.210000000000001 112.528 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -138.37 176.07 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 74.219999999999999 111.123 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 10.8 m -103.96 156.71 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.887 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 64.140000000000001 111.114 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.756 0.312 . . . . 73.129999999999995 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.21 156.08 21.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.055 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.44 149.04 23.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.921 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.75 177.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 70.349999999999994 110.95 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.75 8.73 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.694 -0.765 . . . . 74.040000000000006 112.53 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.57 161.37 32.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 73.310000000000002 110.893 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.18 147.64 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.51 144.89 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 72.420000000000002 110.928 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 p -164.64 177.14 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.510000000000005 110.805 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -49.95 -31.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 64.450000000000003 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -89.87 -36.64 14.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 74.450000000000003 110.932 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 98.25 11.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 65.329999999999998 110.86 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 154.29 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 60.240000000000002 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -123.44 148.25 46.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 70.040000000000006 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 114.14 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.816 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.32 161.15 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 54.32 110.893 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.9 Cg_endo -69.75 -10.68 11.6 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.644 -1.815 . . . . 72.319999999999993 112.304 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.48 104.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.25 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -106.18 137.37 44.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.873 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 15.9 m -73.5 147.38 44.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -87.28 -56.45 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 64.420000000000002 111.126 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.53 69.45 20.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 75.239999999999995 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -8.22 23.05 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 65.219999999999999 112.345 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.86 -31.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 70.549999999999997 111.147 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.788 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -120.39 19.7 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.129999999999995 111.068 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 92.18 0.78 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.799 -0.715 . . . . 64.540000000000006 112.498 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.69 -159.73 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 62.140000000000001 112.407 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.79 174.82 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.340000000000003 111.159 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 8.7 m -103.1 156.19 17.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 53.539999999999999 110.984 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 111.054 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.769 0.319 . . . . 65.430000000000007 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.94 172.09 9.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.399999999999999 111.131 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -92.38 157.79 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.299999999999997 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -51.74 178.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.899 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.54 17.22 25.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 24.23 112.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -113.96 153.96 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 75.030000000000001 110.899 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 28' ' ' ILE . 4.4 t80 -66.6 113.81 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 75.239999999999995 110.869 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -106.53 143.82 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 63.25 110.85 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -149.42 -177.92 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 110.825 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -58.71 -20.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 111.129 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.94 -50.39 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.82 129.98 36.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 63.43 110.963 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 163.16 31.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.873 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -114.84 177.89 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 63.030000000000001 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.02 140.36 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 110.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 3.0 m-20 -50.5 157.67 1.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 55.420000000000002 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -10.47 11.63 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.612 -1.828 . . . . 73.239999999999995 112.344 0.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -48.67 118.37 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 61.420000000000002 110.957 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -122.42 137.47 54.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.851 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 m -72.28 143.69 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.540000000000006 110.962 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -88.1 -60.21 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 71.25 111.126 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -143.3 73.52 17.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.562 0.696 . . . . 73.329999999999998 110.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -8.58 23.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.657 2.238 . . . . 64.010000000000005 112.356 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 25' ' ' ILE . 7.6 p -82.79 -33.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 55.409999999999997 111.111 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -116.73 21.23 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.219999999999999 111.108 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 86.98 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 54.439999999999998 112.558 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.93 -158.51 10.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.711 -0.757 . . . . 61.109999999999999 112.492 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -144.42 174.87 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 44.109999999999999 111.104 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -101.5 151.12 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 65.409999999999997 110.899 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 53.450000000000003 111.053 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.851 0.358 . . . . 74.310000000000002 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.86 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 33.25 111.09 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -89.55 150.38 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 71.430000000000007 110.912 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 175.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.891 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.19 22.83 10.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 52.32 112.478 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.9 mm-40 -130.79 161.6 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 74.510000000000005 110.881 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' ILE . 55.7 t80 -54.62 148.72 11.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 70.129999999999995 110.927 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.3 t -144.94 142.12 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.420000000000002 110.896 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 p -166.54 178.62 5.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.867 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.25 -31.97 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -90.04 -36.96 14.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 72.150000000000006 110.86 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.402 HD13 ' HD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.58 91.44 8.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 30.350000000000001 110.885 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 153.92 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 61.119999999999997 110.867 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -122.97 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 60.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.16 115.39 27.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.858 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.481 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -51.11 162.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 75.019999999999996 110.887 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.7 Cg_endo -69.72 -9.72 11.07 Favored 'Cis proline' 0 C--O 1.232 0.2 0 C-N-CA 122.722 -1.782 . . . . 64.140000000000001 112.302 -0.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.2 104.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 60.439999999999998 110.885 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -104.75 138.73 40.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 54.219999999999999 110.763 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 18.5 m -75.95 146.04 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.030000000000001 110.845 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -78.53 -53.21 7.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.507 . . . . 62.409999999999997 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.06 79.16 14.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 73.209999999999994 110.888 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 62.57 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.73 2.287 . . . . 54.200000000000003 112.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG23 ' A' ' 25' ' ' ILE . 5.3 p -166.91 -35.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 61.030000000000001 111.137 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.806 HG23 HG13 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -106.45 14.67 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.520000000000003 111.092 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.17 56.57 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 63.520000000000003 112.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.99 -164.49 37.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 61.329999999999998 112.531 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -137.77 174.57 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 63.109999999999999 111.162 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 m -100.68 159.11 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.329999999999998 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 63.32 111.112 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.886 0.374 . . . . 72.519999999999996 110.848 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 166.43 23.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 111.132 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.89 153.22 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 61.020000000000003 110.944 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 175.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 110.926 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.22 23.17 7.81 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 65.25 112.506 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -127.13 165.87 18.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 52.240000000000002 110.866 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.451 ' CD2' HD11 ' A' ' 12' ' ' LEU . 73.0 t80 -57.32 142.59 42.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.911 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' LEU . 3.8 t -150.78 113.15 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 110.818 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -111.47 171.66 7.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.0 m -53.82 -25.31 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 51.240000000000002 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -89.72 -54.63 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.917 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 7' ' ' TYR . 1.3 pp -97.98 123.01 41.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 75.510000000000005 110.876 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -121.71 -172.3 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -120.62 -175.18 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 54.020000000000003 110.926 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.43 132.95 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.897 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -49.88 160.68 0.61 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.209999999999994 110.85 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.2 Cg_endo -69.8 -10.27 11.49 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.71 -1.788 . . . . 74.109999999999999 112.35 0.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -47.85 121.8 4.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 64.409999999999997 110.982 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -123.4 144.25 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.484 . . . . 74.439999999999998 110.918 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 152.36 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.925 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -104.84 -22.02 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 63.119999999999997 111.108 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -179.53 76.37 0.19 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.582 0.706 . . . . 72.109999999999999 110.902 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.79 -5.56 16.52 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 70.0 112.345 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.677 HG13 HG23 ' A' ' 25' ' ' ILE . 10.7 p -83.4 -31.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 64.140000000000001 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -115.31 20.49 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 111.096 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.2 62.38 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.78 -0.724 . . . . 64.540000000000006 112.488 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.85 -151.36 24.99 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 75.430000000000007 112.503 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.3 pt -139.71 -178.28 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 75.299999999999997 111.155 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.4 m -105.67 148.8 26.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 14.42 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 111.111 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.837 0.351 . . . . 64.109999999999999 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 12' ' ' LEU . . . -113.13 155.93 24.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.350000000000001 111.074 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.57 159.51 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 72.299999999999997 110.904 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.87 167.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 62.409999999999997 110.909 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 47.26 31.86 6.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 74.230000000000004 112.493 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 159.48 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 51.240000000000002 110.898 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -48.84 149.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.530000000000001 110.934 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.3 t -150.39 141.24 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 64.230000000000004 110.916 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.3 p -165.09 174.5 10.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.956 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 m -51.16 -29.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 54.340000000000003 111.064 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.14 -38.92 13.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.967 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -89.78 106.66 18.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.912 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -81.01 158.44 25.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.019999999999996 110.913 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 t -121.17 146.14 47.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.933 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.1 115.36 30.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.140000000000001 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.21 160.59 0.42 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 110.819 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.0 Cg_endo -69.66 -11.62 11.75 Favored 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 -1.798 . . . . 71.0 112.369 -0.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.6 m-85 -48.05 105.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 71.400000000000006 110.863 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -99.81 149.93 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 74.540000000000006 110.89 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.4 t -85.18 154.83 21.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 74.519999999999996 110.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -98.21 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 64.319999999999993 111.134 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -146.9 78.95 10.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 63.219999999999999 110.931 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -8.17 22.92 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.625 2.216 . . . . 54.32 112.33 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -85.69 -34.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 63.409999999999997 111.154 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.661 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -113.8 24.17 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.239999999999995 111.121 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.96 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.411 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.85 -153.73 11.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 72.109999999999999 112.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.46 174.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 75.439999999999998 111.148 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 86.8 m -96.08 144.33 26.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 54.219999999999999 110.88 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 42.119999999999997 111.173 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.838 0.352 . . . . 74.319999999999993 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.31 175.96 6.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 45.140000000000001 111.102 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.71 125.98 35.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 73.109999999999999 110.901 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -55.99 -175.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 71.420000000000002 110.858 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.95 20.72 6.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.679 -0.772 . . . . 34.310000000000002 112.466 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.589 ' C ' HG22 ' A' ' 28' ' ' ILE . 1.8 mt-10 -134.94 171.54 14.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 73.219999999999999 110.907 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.75 146.27 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 75.329999999999998 110.96 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.42 142.76 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 52.340000000000003 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -149.89 174.79 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 71.540000000000006 110.883 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.8 m -51.66 -28.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 65.450000000000003 111.132 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.76 -46.64 8.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 74.120000000000005 110.926 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.65 113.82 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 65.140000000000001 110.92 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -108.86 155.62 20.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.099999999999994 110.915 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 p -113.77 165.98 12.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 71.109999999999999 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 134.26 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 54.310000000000002 110.876 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -63.63 166.55 9.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 61.020000000000003 110.905 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.73 -14.51 12.44 Favored 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.723 -1.782 . . . . 71.140000000000001 112.332 0.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 4' ' ' LYS . 12.0 m-85 -48.21 116.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 70.010000000000005 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -117.88 146.78 43.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 74.010000000000005 110.844 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 13.8 m -70.01 147.56 49.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 110.882 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 p -85.89 -50.88 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.409999999999997 111.126 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -150.08 76.09 8.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.634 0.73 . . . . 75.329999999999998 110.971 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -7.67 21.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 51.020000000000003 112.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 25' ' ' ILE . 7.5 p -84.15 -33.72 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 51.130000000000003 111.172 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.741 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.73 18.98 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 111.128 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.16 84.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 72.049999999999997 112.488 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.93 -156.08 9.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 70.0 112.448 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.589 HG22 ' C ' ' A' ' 6' ' ' GLU . 1.2 pt -140.29 166.47 19.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 74.120000000000005 111.075 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 56.5 m -100.23 155.36 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 54.119999999999997 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 63.0 111.08 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.864 0.364 . . . . 71.129999999999995 110.869 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.51 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.510000000000005 111.127 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -89.47 158.41 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 74.010000000000005 110.985 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -55.82 171.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 110.905 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.37 4.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 55.43 112.474 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 157.93 44.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 72.439999999999998 110.884 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -48.46 149.73 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.099999999999994 110.889 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 t -150.73 140.28 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 53.039999999999999 110.937 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 51.7 p -165.12 174.25 10.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.549999999999997 110.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.7 m -50.63 -29.4 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.319999999999993 111.152 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -89.05 -38.35 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.540000000000006 110.933 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 105.57 17.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 61.43 110.942 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -77.32 158.93 29.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 54.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -126.62 145.03 50.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.884 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 117.07 33.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 70.120000000000005 110.962 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -51.0 162.54 0.58 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 110.886 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -11.03 11.89 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.669 -1.805 . . . . 54.329999999999998 112.318 0.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -49.07 104.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 73.420000000000002 110.907 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -98.85 151.84 20.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 75.109999999999999 110.856 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -78.71 160.99 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.856 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 -27.01 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 62.329999999999998 111.056 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 25' ' ' ILE . 33.9 mt-30 -154.41 64.09 4.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 70.510000000000005 110.905 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.8 -6.97 19.88 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.638 2.225 . . . . 14.23 112.354 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -99.25 -35.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 111.136 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -118.53 34.67 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.509999999999998 111.171 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.63 101.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.765 . . . . 63.009999999999998 112.461 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.61 -142.25 5.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.825 -0.702 . . . . 53.130000000000003 112.561 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.72 175.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 74.239999999999995 111.148 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 97.7 m -101.7 138.59 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 72.340000000000003 110.906 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.030000000000001 111.061 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 71.540000000000006 110.963 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 159.09 15.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 73.319999999999993 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.14 157.88 18.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 62.109999999999999 110.924 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.79 167.0 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 70.510000000000005 110.883 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 45.42 36.64 5.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 70.400000000000006 112.539 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' HG22 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -131.09 160.1 35.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.873 0.368 . . . . 62.009999999999998 110.895 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.86 149.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 72.329999999999998 110.883 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.3 t -150.38 141.8 23.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 74.400000000000006 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 100.0 p -154.2 -178.28 7.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.209999999999994 110.847 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -55.95 -38.49 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 73.200000000000003 111.161 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -89.11 -27.19 20.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 75.109999999999999 110.969 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 101.3 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 74.200000000000003 110.948 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -88.26 159.21 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.978 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.51 148.75 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 110.866 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.35 119.77 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 52.32 110.825 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 1.2 m-20 -50.16 162.32 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.611 0.72 . . . . 74.310000000000002 110.912 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.78 -10.86 11.73 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 -1.793 . . . . 64.510000000000005 112.303 0.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -48.92 103.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 64.150000000000006 110.895 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -98.81 149.79 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.340000000000003 110.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -83.83 154.39 23.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.049999999999997 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 p -98.36 -66.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 62.25 111.109 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -139.05 80.12 24.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 74.239999999999995 110.9 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -7.85 22.13 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.655 2.236 . . . . 74.140000000000001 112.294 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG23 ' A' ' 25' ' ' ILE . 7.7 p -85.46 -34.08 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 45.530000000000001 111.133 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.712 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.06 22.98 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 64.540000000000006 111.118 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.08 84.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.702 -0.761 . . . . 41.450000000000003 112.448 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.26 -156.25 12.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.738 . . . . 52.530000000000001 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -143.74 174.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.966 0.412 . . . . 74.319999999999993 111.087 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 36.5 m -92.41 144.8 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 41.119999999999997 110.857 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 72.420000000000002 111.143 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 71.219999999999999 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.34 161.24 21.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 53.350000000000001 111.068 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.78 152.52 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.439999999999998 110.938 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 178.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.928 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.92 21.79 10.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 72.030000000000001 112.512 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -128.74 155.26 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.356 . . . . 74.010000000000005 110.855 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.696 ' O ' HD22 ' A' ' 12' ' ' LEU . 38.9 t80 -60.74 124.58 20.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 110.868 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.7 t -118.3 142.57 47.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 71.120000000000005 110.939 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.5 p -164.28 -179.32 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 72.230000000000004 110.91 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -51.72 -29.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 111.161 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -93.43 -36.62 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 75.230000000000004 110.934 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -89.55 89.82 8.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 72.140000000000001 110.95 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -64.13 152.37 40.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.430000000000007 110.952 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -127.06 139.93 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 60.229999999999997 110.877 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -100.89 119.96 39.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 64.510000000000005 110.835 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -51.84 163.11 0.68 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.627 0.727 . . . . 70.030000000000001 110.867 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.75 -10.45 11.49 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.623 -1.824 . . . . 75.310000000000002 112.389 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.8 m-85 -47.37 104.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 74.400000000000006 110.92 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -102.06 138.71 38.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 62.219999999999999 110.811 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.3 m -75.58 150.35 38.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 110.809 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -98.87 -25.15 14.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 63.310000000000002 111.09 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.507 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 13.9 mp0 -154.52 86.73 3.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.519 0.676 . . . . 73.150000000000006 110.942 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.31 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.623 2.215 . . . . 72.329999999999998 112.408 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.698 HG13 HD13 ' A' ' 25' ' ' ILE . 8.0 p -100.51 7.68 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.299999999999997 111.148 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.698 HD13 HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -124.36 10.62 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.420000000000002 111.186 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.81 99.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 63.329999999999998 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 22' ' ' GLN . . . -150.82 -155.98 7.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 75.0 112.562 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -137.56 -179.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 74.310000000000002 111.136 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 24.0 m -106.48 151.09 25.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.912 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 74.099999999999994 111.107 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.833 0.349 . . . . 52.549999999999997 110.918 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.49 156.62 23.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 64.129999999999995 111.097 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.47 148.56 23.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 72.329999999999998 110.929 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 177.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.87 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.66 22.73 8.78 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.674 -0.774 . . . . 54.409999999999997 112.462 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.2 mm-40 -131.91 162.84 29.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 54.399999999999999 110.877 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' HA ' HG22 ' A' ' 28' ' ' ILE . 48.6 t80 -56.7 148.77 19.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.957 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.1 t -148.81 145.05 27.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 72.299999999999997 110.878 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.3 p -164.26 177.57 8.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 73.420000000000002 110.788 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 m -49.82 -31.39 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 111.13 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.02 -36.74 14.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.93 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.44 96.26 10.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 52.450000000000003 110.865 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.54 152.46 39.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 64.129999999999995 110.918 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -120.77 147.54 45.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 54.020000000000003 110.909 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.1 114.04 26.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 33.219999999999999 110.9 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.12 161.09 0.38 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.539 0.685 . . . . 72.409999999999997 110.845 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.78 -10.44 11.55 Favored 'Cis proline' 0 C--O 1.232 0.22 0 C-N-CA 122.63 -1.821 . . . . 74.099999999999994 112.299 -0.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -46.36 104.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 71.129999999999995 110.925 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -106.16 137.58 43.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 74.040000000000006 110.854 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 22.9 m -73.17 147.08 45.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 61.32 110.911 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 p -87.27 -50.59 6.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 70.430000000000007 111.134 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -149.36 68.71 9.41 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.567 0.699 . . . . 73.329999999999998 110.942 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.27 23.17 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.699 2.266 . . . . 42.520000000000003 112.348 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.797 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.89 -31.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 73.540000000000006 111.093 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.797 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -120.3 19.2 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 71.549999999999997 111.138 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.41 92.99 0.81 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 73.530000000000001 112.517 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.06 -160.36 8.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.704 -0.76 . . . . 35.210000000000001 112.528 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -138.37 176.07 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 74.219999999999999 111.123 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 10.8 m -103.96 156.71 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.887 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 64.140000000000001 111.114 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.756 0.312 . . . . 73.129999999999995 110.921 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.21 156.08 21.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.055 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.44 149.04 23.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.921 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.75 177.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 70.349999999999994 110.95 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 22.75 8.73 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.694 -0.765 . . . . 74.040000000000006 112.53 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.57 161.37 32.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 73.310000000000002 110.893 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -55.18 147.64 15.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 63.420000000000002 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.51 144.89 28.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 72.420000000000002 110.928 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.1 p -164.64 177.14 8.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 73.510000000000005 110.805 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.3 m -49.95 -31.19 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 64.450000000000003 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -89.87 -36.64 14.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 74.450000000000003 110.932 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.43 98.25 11.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 65.329999999999998 110.86 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.52 154.29 36.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 60.240000000000002 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -123.44 148.25 46.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 70.040000000000006 110.877 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 114.14 27.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.816 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.32 161.15 0.39 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.582 0.706 . . . . 54.32 110.893 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.9 Cg_endo -69.75 -10.68 11.6 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.644 -1.815 . . . . 72.319999999999993 112.304 0.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -46.48 104.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.25 110.939 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -106.18 137.37 44.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.873 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 15.9 m -73.5 147.38 44.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.851 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -87.28 -56.45 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 64.420000000000002 111.126 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.8 mm100 -142.53 69.45 20.82 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.601 0.715 . . . . 75.239999999999995 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -8.22 23.05 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.672 2.248 . . . . 65.219999999999999 112.345 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.788 HG13 HG23 ' A' ' 25' ' ' ILE . 7.3 p -84.86 -31.22 7.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 70.549999999999997 111.147 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.788 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -120.39 19.7 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.129999999999995 111.068 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.85 92.18 0.78 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.799 -0.715 . . . . 64.540000000000006 112.498 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.69 -159.73 9.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 62.140000000000001 112.407 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.79 174.82 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 63.340000000000003 111.159 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 8.7 m -103.1 156.19 17.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.42 . . . . 53.539999999999999 110.984 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 111.054 179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.769 0.319 . . . . 65.430000000000007 110.919 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.94 172.09 9.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 54.399999999999999 111.131 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -92.38 157.79 16.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 74.299999999999997 110.909 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -51.74 178.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.899 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 57.54 17.22 25.53 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.712 -0.756 . . . . 24.23 112.515 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -113.96 153.96 28.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.854 0.359 . . . . 75.030000000000001 110.899 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 28' ' ' ILE . 4.4 t80 -66.6 113.81 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 75.239999999999995 110.869 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -106.53 143.82 34.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.517 . . . . 63.25 110.85 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -149.42 -177.92 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 64.219999999999999 110.825 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.8 m -58.71 -20.17 16.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 111.129 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.94 -50.39 3.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 110.948 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.82 129.98 36.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 63.43 110.963 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.36 163.16 31.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.873 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -114.84 177.89 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 63.030000000000001 110.907 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.02 140.36 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 110.847 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PRO . 3.0 m-20 -50.5 157.67 1.21 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.635 0.731 . . . . 55.420000000000002 110.866 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -10.47 11.63 Favored 'Cis proline' 0 C--N 1.342 0.205 0 C-N-CA 122.612 -1.828 . . . . 73.239999999999995 112.344 0.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -48.67 118.37 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 61.420000000000002 110.957 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 -122.42 137.47 54.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.851 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 m -72.28 143.69 48.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.540000000000006 110.962 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -88.1 -60.21 2.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 71.25 111.126 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -143.3 73.52 17.72 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.562 0.696 . . . . 73.329999999999998 110.897 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -8.58 23.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.657 2.238 . . . . 64.010000000000005 112.356 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 25' ' ' ILE . 7.6 p -82.79 -33.8 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 55.409999999999997 111.111 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -116.73 21.23 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.219999999999999 111.108 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.65 86.98 0.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.741 -0.742 . . . . 54.439999999999998 112.558 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.93 -158.51 10.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.711 -0.757 . . . . 61.109999999999999 112.492 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -144.42 174.87 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.946 0.403 . . . . 44.109999999999999 111.104 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -101.5 151.12 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 65.409999999999997 110.899 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 53.450000000000003 111.053 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.851 0.358 . . . . 74.310000000000002 110.899 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.32 158.86 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 33.25 111.09 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -89.55 150.38 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 71.430000000000007 110.912 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.96 175.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.891 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.19 22.83 10.77 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.809 -0.71 . . . . 52.32 112.478 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' C ' HG22 ' A' ' 28' ' ' ILE . 2.9 mm-40 -130.79 161.6 31.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 74.510000000000005 110.881 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.431 ' HA ' HG22 ' A' ' 28' ' ' ILE . 55.7 t80 -54.62 148.72 11.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 70.129999999999995 110.927 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.3 t -144.94 142.12 29.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.420000000000002 110.896 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.3 p -166.54 178.62 5.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.184 -0.462 . . . . 61.240000000000002 110.867 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -51.25 -31.97 12.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 111.175 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -90.04 -36.96 14.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 72.150000000000006 110.86 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.402 HD13 ' HD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.58 91.44 8.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 30.350000000000001 110.885 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.91 153.92 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 61.119999999999997 110.867 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -122.97 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 60.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.16 115.39 27.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.858 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.481 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.6 OUTLIER -51.11 162.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.6 0.714 . . . . 75.019999999999996 110.887 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.7 Cg_endo -69.72 -9.72 11.07 Favored 'Cis proline' 0 C--O 1.232 0.2 0 C-N-CA 122.722 -1.782 . . . . 64.140000000000001 112.302 -0.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -46.2 104.67 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 60.439999999999998 110.885 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -104.75 138.73 40.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 54.219999999999999 110.763 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 18.5 m -75.95 146.04 39.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.030000000000001 110.845 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 p -78.53 -53.21 7.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.507 . . . . 62.409999999999997 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.06 79.16 14.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.537 0.684 . . . . 73.209999999999994 110.888 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 62.57 1.8 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.73 2.287 . . . . 54.200000000000003 112.292 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG23 ' A' ' 25' ' ' ILE . 5.3 p -166.91 -35.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 61.030000000000001 111.137 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.806 HG23 HG13 ' A' ' 24' ' ' VAL . 0.6 OUTLIER -106.45 14.67 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 61.520000000000003 111.092 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.17 56.57 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 63.520000000000003 112.447 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.99 -164.49 37.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 61.329999999999998 112.531 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.1 pt -137.77 174.57 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.833 0.349 . . . . 63.109999999999999 111.162 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 15.6 m -100.68 159.11 15.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 62.329999999999998 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 63.32 111.112 179.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.886 0.374 . . . . 72.519999999999996 110.848 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.91 166.43 23.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 111.132 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.89 153.22 18.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 61.020000000000003 110.944 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.35 175.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 72.129999999999995 110.926 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.22 23.17 7.81 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 65.25 112.506 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -127.13 165.87 18.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 52.240000000000002 110.866 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.451 ' CD2' HD11 ' A' ' 12' ' ' LEU . 73.0 t80 -57.32 142.59 42.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 73.200000000000003 110.911 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.434 ' HA ' HD12 ' A' ' 12' ' ' LEU . 3.8 t -150.78 113.15 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 110.818 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.9 p -111.47 171.66 7.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.430000000000007 110.907 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.0 m -53.82 -25.31 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 51.240000000000002 111.115 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -89.72 -54.63 3.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.917 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 7' ' ' TYR . 1.3 pp -97.98 123.01 41.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.062 -0.517 . . . . 75.510000000000005 110.876 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -121.71 -172.3 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 73.439999999999998 110.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -120.62 -175.18 2.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 54.020000000000003 110.926 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -105.43 132.95 50.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.897 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -49.88 160.68 0.61 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.209999999999994 110.85 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.2 Cg_endo -69.8 -10.27 11.49 Favored 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.71 -1.788 . . . . 74.109999999999999 112.35 0.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -47.85 121.8 4.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 64.409999999999997 110.982 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -123.4 144.25 49.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.484 . . . . 74.439999999999998 110.918 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.44 152.36 44.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.925 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -104.84 -22.02 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 63.119999999999997 111.108 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -179.53 76.37 0.19 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.582 0.706 . . . . 72.109999999999999 110.902 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.79 -5.56 16.52 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.679 2.253 . . . . 70.0 112.345 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.677 HG13 HG23 ' A' ' 25' ' ' ILE . 10.7 p -83.4 -31.87 8.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 64.140000000000001 111.119 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.677 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -115.31 20.49 6.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 62.049999999999997 111.096 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.2 62.38 3.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.78 -0.724 . . . . 64.540000000000006 112.488 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.85 -151.36 24.99 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 75.430000000000007 112.503 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.3 pt -139.71 -178.28 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.798 0.333 . . . . 75.299999999999997 111.155 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 32.4 m -105.67 148.8 26.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 14.42 110.871 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 111.111 179.889 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.837 0.351 . . . . 64.109999999999999 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 12' ' ' LEU . . . -113.13 155.93 24.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 63.350000000000001 111.074 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.57 159.51 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 72.299999999999997 110.904 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.87 167.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 62.409999999999997 110.909 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 47.26 31.86 6.59 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.773 -0.727 . . . . 74.230000000000004 112.493 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.04 159.48 36.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 51.240000000000002 110.898 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -48.84 149.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.530000000000001 110.934 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.3 t -150.39 141.24 22.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 64.230000000000004 110.916 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.3 p -165.09 174.5 10.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.956 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 m -51.16 -29.17 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 54.340000000000003 111.064 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.14 -38.92 13.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.967 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.423 HD12 ' HB2' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -89.78 106.66 18.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 74.239999999999995 110.912 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -81.01 158.44 25.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 73.019999999999996 110.913 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.8 t -121.17 146.14 47.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 110.933 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.1 115.36 30.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 51.140000000000001 110.893 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.506 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -48.21 160.59 0.42 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 110.819 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 54.0 Cg_endo -69.66 -11.62 11.75 Favored 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 -1.798 . . . . 71.0 112.369 -0.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.407 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.6 m-85 -48.05 105.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 71.400000000000006 110.863 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -99.81 149.93 22.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 74.540000000000006 110.89 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.4 t -85.18 154.83 21.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.238 -0.437 . . . . 74.519999999999996 110.843 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.6 p -98.21 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 64.319999999999993 111.134 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -146.9 78.95 10.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 63.219999999999999 110.931 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -8.17 22.92 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.625 2.216 . . . . 54.32 112.33 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -85.69 -34.49 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 63.409999999999997 111.154 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.661 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -113.8 24.17 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.239999999999995 111.121 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.96 85.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.775 -0.726 . . . . 63.32 112.411 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.85 -153.73 11.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.79 -0.719 . . . . 72.109999999999999 112.542 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.1 pt -143.46 174.0 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 75.439999999999998 111.148 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 86.8 m -96.08 144.33 26.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.12 -0.491 . . . . 54.219999999999999 110.88 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 42.119999999999997 111.173 179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.838 0.352 . . . . 74.319999999999993 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.31 175.96 6.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 45.140000000000001 111.102 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.71 125.98 35.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 73.109999999999999 110.901 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -55.99 -175.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 71.420000000000002 110.858 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.95 20.72 6.63 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.679 -0.772 . . . . 34.310000000000002 112.466 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.589 ' C ' HG22 ' A' ' 28' ' ' ILE . 1.8 mt-10 -134.94 171.54 14.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 73.219999999999999 110.907 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -51.75 146.27 8.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 75.329999999999998 110.96 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.42 142.76 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 52.340000000000003 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.0 p -149.89 174.79 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 71.540000000000006 110.883 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.8 m -51.66 -28.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 65.450000000000003 111.132 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -89.76 -46.64 8.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 74.120000000000005 110.926 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.65 113.82 25.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 65.140000000000001 110.92 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -108.86 155.62 20.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.099999999999994 110.915 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.4 p -113.77 165.98 12.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 71.109999999999999 110.879 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.41 134.26 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 54.310000000000002 110.876 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -63.63 166.55 9.1 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 61.020000000000003 110.905 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.73 -14.51 12.44 Favored 'Cis proline' 0 C--N 1.341 0.137 0 C-N-CA 122.723 -1.782 . . . . 71.140000000000001 112.332 0.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.407 ' CG ' ' HB3' ' A' ' 4' ' ' LYS . 12.0 m-85 -48.21 116.3 1.5 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 70.010000000000005 110.954 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -117.88 146.78 43.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 74.010000000000005 110.844 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 13.8 m -70.01 147.56 49.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 110.882 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 p -85.89 -50.88 6.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 73.409999999999997 111.126 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -150.08 76.09 8.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.634 0.73 . . . . 75.329999999999998 110.971 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -7.67 21.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 51.020000000000003 112.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 25' ' ' ILE . 7.5 p -84.15 -33.72 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 51.130000000000003 111.172 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.741 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.73 18.98 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 111.128 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 78.16 84.35 0.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.788 -0.72 . . . . 72.049999999999997 112.488 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.93 -156.08 9.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.757 -0.735 . . . . 70.0 112.448 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.589 HG22 ' C ' ' A' ' 6' ' ' GLU . 1.2 pt -140.29 166.47 19.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 74.120000000000005 111.075 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.893 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 56.5 m -100.23 155.36 17.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 54.119999999999997 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 63.0 111.08 179.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.864 0.364 . . . . 71.129999999999995 110.869 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.31 154.51 21.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 74.510000000000005 111.127 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -89.47 158.41 17.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 74.010000000000005 110.985 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -55.82 171.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 110.905 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.14 32.37 4.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.841 -0.695 . . . . 55.43 112.474 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 157.93 44.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 72.439999999999998 110.884 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -48.46 149.73 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.099999999999994 110.889 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 t -150.73 140.28 21.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.115 -0.493 . . . . 53.039999999999999 110.937 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 51.7 p -165.12 174.25 10.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 63.549999999999997 110.862 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 23' ' ' PRO . 7.7 m -50.63 -29.4 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.319999999999993 111.152 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -89.05 -38.35 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.540000000000006 110.933 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.79 105.57 17.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 61.43 110.942 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.3 tp60 -77.32 158.93 29.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 54.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -126.62 145.03 50.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.884 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 117.07 33.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 70.120000000000005 110.962 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.484 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -51.0 162.54 0.58 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 110.886 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.82 -11.03 11.89 Favored 'Cis proline' 0 C--O 1.231 0.174 0 C-N-CA 122.669 -1.805 . . . . 54.329999999999998 112.318 0.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -49.07 104.25 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.271 -0.422 . . . . 73.420000000000002 110.907 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -98.85 151.84 20.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.039 -0.528 . . . . 75.109999999999999 110.856 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.5 t -78.71 160.99 27.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.856 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 -27.01 6.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 62.329999999999998 111.056 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 25' ' ' ILE . 33.9 mt-30 -154.41 64.09 4.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.597 0.713 . . . . 70.510000000000005 110.905 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 10' ' ' VAL . 53.3 Cg_endo -69.8 -6.97 19.88 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.638 2.225 . . . . 14.23 112.354 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 25' ' ' ILE . 7.4 p -99.25 -35.78 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 74.519999999999996 111.136 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.531 HG23 HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -118.53 34.67 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.509999999999998 111.171 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.63 101.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.765 . . . . 63.009999999999998 112.461 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.61 -142.25 5.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.825 -0.702 . . . . 53.130000000000003 112.561 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.72 175.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.885 0.374 . . . . 74.239999999999995 111.148 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 97.7 m -101.7 138.59 38.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 72.340000000000003 110.906 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.030000000000001 111.061 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 71.540000000000006 110.963 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.06 159.09 15.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 73.319999999999993 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.14 157.88 18.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 62.109999999999999 110.924 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -57.79 167.0 1.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 70.510000000000005 110.883 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 45.42 36.64 5.96 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 70.400000000000006 112.539 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.415 ' C ' HG22 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -131.09 160.1 35.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.873 0.368 . . . . 62.009999999999998 110.895 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -48.86 149.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 72.329999999999998 110.883 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.3 t -150.38 141.8 23.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 74.400000000000006 110.9 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 100.0 p -154.2 -178.28 7.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 64.209999999999994 110.847 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -55.95 -38.49 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.498 . . . . 73.200000000000003 111.161 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -89.11 -27.19 20.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 75.109999999999999 110.969 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 101.3 14.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 74.200000000000003 110.948 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -88.26 159.21 18.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.239999999999995 110.978 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.51 148.75 45.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 110.866 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.35 119.77 31.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 52.32 110.825 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 1.2 m-20 -50.16 162.32 0.51 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.611 0.72 . . . . 74.310000000000002 110.912 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.6 Cg_endo -69.78 -10.86 11.73 Favored 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.697 -1.793 . . . . 64.510000000000005 112.303 0.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -48.92 103.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 64.150000000000006 110.895 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -98.81 149.79 22.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 74.340000000000003 110.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.0 t -83.83 154.39 23.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.049999999999997 110.927 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 p -98.36 -66.12 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 62.25 111.109 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -139.05 80.12 24.72 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.526 0.679 . . . . 74.239999999999995 110.9 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -7.85 22.13 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.655 2.236 . . . . 74.140000000000001 112.294 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.712 HG13 HG23 ' A' ' 25' ' ' ILE . 7.7 p -85.46 -34.08 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 45.530000000000001 111.133 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.712 HG23 HG13 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -114.06 22.98 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 64.540000000000006 111.118 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.08 84.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.702 -0.761 . . . . 41.450000000000003 112.448 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.26 -156.25 12.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.738 . . . . 52.530000000000001 112.517 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 HG22 ' C ' ' A' ' 6' ' ' GLU . 0.9 OUTLIER -143.74 174.14 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.966 0.412 . . . . 74.319999999999993 111.087 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 4' ' ' LYS . 36.5 m -92.41 144.8 25.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 41.119999999999997 110.857 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 72.420000000000002 111.143 179.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 71.219999999999999 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.34 161.24 21.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 53.350000000000001 111.068 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.78 152.52 21.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 72.439999999999998 110.938 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' O ' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -52.79 178.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.928 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.92 21.79 10.87 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.783 -0.722 . . . . 72.030000000000001 112.512 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -128.74 155.26 45.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.356 . . . . 74.010000000000005 110.855 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.696 ' O ' HD22 ' A' ' 12' ' ' LEU . 38.9 t80 -60.74 124.58 20.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 110.868 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.7 t -118.3 142.57 47.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 71.120000000000005 110.939 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.5 p -164.28 -179.32 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 72.230000000000004 110.91 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -51.72 -29.75 10.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 111.161 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -93.43 -36.62 12.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 75.230000000000004 110.934 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.696 HD22 ' O ' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -89.55 89.82 8.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 72.140000000000001 110.95 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -64.13 152.37 40.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 71.430000000000007 110.952 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t -127.06 139.93 52.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 60.229999999999997 110.877 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -100.89 119.96 39.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 64.510000000000005 110.835 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -51.84 163.11 0.68 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.627 0.727 . . . . 70.030000000000001 110.867 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 16' ' ' ASP . 53.4 Cg_endo -69.75 -10.45 11.49 Favored 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.623 -1.824 . . . . 75.310000000000002 112.389 -0.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' CYS . 5.8 m-85 -47.37 104.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.431 . . . . 74.400000000000006 110.92 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.8 p-80 -102.06 138.71 38.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 62.219999999999999 110.811 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 12.3 m -75.58 150.35 38.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 74.409999999999997 110.809 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 33.6 p -98.87 -25.15 14.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 63.310000000000002 111.09 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.507 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 13.9 mp0 -154.52 86.73 3.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.519 0.676 . . . . 73.150000000000006 110.942 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -50.31 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.623 2.215 . . . . 72.329999999999998 112.408 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.698 HG13 HD13 ' A' ' 25' ' ' ILE . 8.0 p -100.51 7.68 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 72.299999999999997 111.148 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.698 HD13 HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -124.36 10.62 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 71.420000000000002 111.186 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.81 99.19 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.741 -0.742 . . . . 63.329999999999998 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 22' ' ' GLN . . . -150.82 -155.98 7.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.812 -0.709 . . . . 75.0 112.562 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.574 HG22 ' HA ' ' A' ' 7' ' ' TYR . 1.0 OUTLIER -137.56 -179.09 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.896 0.379 . . . . 74.310000000000002 111.136 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 24.0 m -106.48 151.09 25.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.912 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 74.099999999999994 111.107 179.863 . . . . . . . . 0 0 . 1 stop_ save_